Specialists for Immune-mediated thrombotic thrombocytopenic purpura

34 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Paul Coppo
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques (CNR-MAT)
QC-verified 15
Pascale Poullin
Rare Disease / Clinical Research
French Reference Center for Thrombotic Microangiopathies; APHM
QC-verified 7
Kazuya Sakai
Rare Disease / Clinical Research
Laboratory for Thrombosis Research
QC-verified 7
Raïda Bouzid
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques (CNR-MAT)
QC-verified 7
Agnès Veyradier
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques (CNR-MAT)
QC-verified 10
Julia Weisinger
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques (CNR-MAT)
QC-verified 3
Bérangère Joly
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques et Service d'hématologie
QC-verified 3
Alain Wynckel
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques (CNR-MAT)
QC-verified 4
Elie Azoulay
Rare Disease / Clinical Research
Paris University
QC-verified 4
Flora Peyvandi
Rare Disease / Clinical Research
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
QC-verified 4
Pasquale Agosti
Rare Disease / Clinical Research
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
QC-verified 4
Bérangère S Joly
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques et Service d'hématologie
QC-verified 5
Masanori Matsumoto
Rare Disease / Clinical Research
Nara Medical University
QC-verified 5
Ygal Benhamou
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques
QC-verified 6
Xiaohui Zhang, MD, MD
Peking University People's Hospital
PI×12
Ilaria Mancini, PhD
Rare Disease / Clinical Research
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
PI×1
Marshall Mazepa, MD, M.D
Rare Disease / Clinical Research
University of Minnesota
MINNEAPOLIS, MN
PI×1
Xiao-Hui Zhang, MD
Rare Disease / Clinical Research
Peking University Institute of Hematology, Peking University People's Hospital
PI×16
Ilaria Mancini
Rare Disease / Clinical Research
Università degli Studi di Milano
3
Linus Alexander Völker
Rare Disease / Clinical Research
University Hospital Cologne
2
Christopher J Patriquin
Rare Disease / Clinical Research
University Health Network
2
Marienn Réti
Rare Disease / Clinical Research
Central Hospital of Southern Pest - Institute of Hematology and Infectious Diseases
2
Cristina Pascual-Izquierdo
Rare Disease / Clinical Research
Hospital Universitario Gregorio Marañón
2
John-Paul Westwood
Rare Disease / Clinical Research
University College London Hospital (UCLH)
2
Mari R Thomas
Rare Disease / Clinical Research
University College London Hospital (UCLH)
2
Javier de la Rubia
Rare Disease / Clinical Research
University Hospital La Fe and School of Medicine and Dentistry
2
Zoltán Prohászka
Rare Disease / Clinical Research
Semmelweis University and Research Group for Immunology and Haematology
3
François Provôt
Rare Disease / Clinical Research
France. francois.provot@chru-lille.fr.
3
Camila Masias, M.D
Rare Disease / Clinical Research
Baptist Health South Florida
MIAMI, FL
3
Katerina Pavenski
Rare Disease / Clinical Research
St. Michael's Hospital
3
Jehane Fadlallah
Rare Disease / Clinical Research
Centre de Référence des Microangiopathies Thrombotiques et Service d'hématologie
3
Karen Vanhoorelbeke
Rare Disease / Clinical Research
Laboratory for Thrombosis Research
4
György Sinkovits
Rare Disease / Clinical Research
Semmelweis University and Research Group for Immunology and Haematology
4
X Long Zheng, M.D., Ph.D
Rare Disease / Clinical Research
University of Kansas Medical Center
KANSAS CITY, KS
2

More about Immune-mediated thrombotic thrombocytopenic purpura